Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-15

FDA Approved: DATSCAN — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)

View source ↗

Summary

This is a supplemental FDA approval for DATSCAN (ioflupane I-123) as a dopamine transporter imaging agent. It helps in evaluating suspected Parkinsonian syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DaTscan (ioflupane)

Snippet

SUPPL AP for DATSCAN (IOFLUPANE I-123)